Thursday, April 02, 2015 6:52:52 PM
." The objective is to create shareholder value by setting into motion the amount of $5 million to $25 million and make funds raises required to take the Company to the next level. The medical cannabis industry is undergoing a revolution and with that all market participants should be prepared to take informed decisions."
He set a billion+ plus shares in motion...lol...isn't he rich enough trading the bogat trust and issuing news ...my goodness man...stop the presses...California 4 months late already....won't address the issue
Europe and Spain 8 product release right after California release....won't address the issue
The best ...the mythical spainabis unveiling ... Only 5 products....try to buy some ...not even the photoshop pic of the 5.... There is one pic floating around of three.mythical products..lol...his global release and he didn't even go...nor did his European guru it appears...as a matter of fact the guy doesn't even claim to work for Cbis .....kind like Kane's beer and his big dupetit scam....endo... Johnson your just going to let all your believers down...take their money and say nothing...do nothing....really dude....expect that from Dabney but not from a Harvard guy. Wtf....
These are the kind of guys trying to sell bags of oregano at Dave concerts it appears....
Yo Dabney,let's talk about Canada dude .........
Call me crazy Dabney but didn't Cbis investors pay for and create the product you passed off to Kane to run his endo scam while you were running your FDA scam the Kane blew up so you had Johnson and bray further defraud shareholders with lofty stories of the future and all your supposed products then whe that scam fell apart you took back our patented product and now are handing it over to another company run by the same scammer who defrauded all the poor investors at endo...really you think you can get away with this you liar and documented stock scammer.......really now ...you are one bold thief and liar I'll give you that Dabney
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM